HCA Healthcare Inc (NYSE:HCA) Shares Purchased by Westpac Banking Corp

Westpac Banking Corp increased its position in shares of HCA Healthcare Inc (NYSE:HCA) by 13.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 353,407 shares of the company’s stock after purchasing an additional 41,250 shares during the period. HCA Healthcare accounts for about 0.7% of Westpac Banking Corp’s holdings, making the stock its 17th biggest holding. Westpac Banking Corp owned approximately 0.10% of HCA Healthcare worth $47,770,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in HCA. Westside Investment Management Inc. purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $34,000. NEXT Financial Group Inc purchased a new position in HCA Healthcare in the second quarter worth approximately $43,000. Financial Gravity Wealth Inc. purchased a new position in HCA Healthcare in the first quarter worth approximately $47,000. Valeo Financial Advisors LLC purchased a new position in HCA Healthcare in the first quarter worth approximately $66,000. Finally, Rational Advisors LLC lifted its stake in HCA Healthcare by 5,118.2% in the first quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after acquiring an additional 563 shares during the last quarter. Hedge funds and other institutional investors own 70.23% of the company’s stock.

Shares of HCA Healthcare stock traded up $2.32 during trading on Tuesday, reaching $128.12. The company’s stock had a trading volume of 46,820 shares, compared to its average volume of 1,861,999. The stock has a 50-day moving average price of $135.74. The company has a market capitalization of $43.48 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.09 and a beta of 0.85. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42.



HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing analysts’ consensus estimates of $2.49 by ($0.28). The business had revenue of $12.60 billion during the quarter, compared to analyst estimates of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. The business’s revenue was up 9.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.29 earnings per share. On average, equities research analysts forecast that HCA Healthcare Inc will post 10.35 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, August 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.25%. HCA Healthcare’s payout ratio is 16.38%.

A number of brokerages recently issued reports on HCA. Goldman Sachs Group upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $147.00 to $160.00 in a research note on Wednesday, July 10th. Mizuho set a $153.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Raymond James upgraded shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $115.00 to $135.00 in a research note on Tuesday, April 23rd. UBS Group lifted their price target on shares of HCA Healthcare from $172.00 to $181.00 and gave the stock a “buy” rating in a research note on Monday, June 24th. Finally, Barclays decreased their price target on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have issued a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and an average target price of $153.35.

In other news, major shareholder Patricia F. Elcan acquired 250 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were bought at an average cost of $124.10 per share, with a total value of $31,025.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Robert A. Waterman sold 33,786 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the completion of the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at $37,733,793.98. The disclosure for this sale can be found here. Insiders own 2.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Cash Flow Analysis in Stock Selection

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.